Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Elevance Health, Inc. Director's Dealing 2012

May 18, 2012

29933_dirs_2012-05-18_1d8b7614-c839-4007-8caf-93a35d739c12.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WELLPOINT, INC (WLP)
CIK: 0001156039
Period of Report: 2012-05-16

Reporting Person: JOBE WARREN Y (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-03-13 Common Stock G 250 Disposed 7610 Direct
2012-03-14 Common Stock G 250 Disposed 7360 Direct
2012-05-16 Common Stock M 2946 Acquired 10306 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-05-16 Phantom Stock Units $ M 2946 Disposed 2012-05-16 Common Stock (2946) Direct
2012-05-16 Phantom Stock Units $ A 2681 Acquired Common Stock (2681) Direct

Footnotes

F1: Phantom stock units converted to Company common stock on a 1-for-1 basis in accordance with the terms of the WellPoint, Inc ("Company") Board of Directors Deferred Compensation Plan (the "Plan").

F2: The phantom stock units were accrued under the Plan.

F3: The Conversion or Exercise Price of the Derivative Security is 1-for-1.

F4: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Plan in accordance with the terms of the Plan.